Founders Financial Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Sell |
7,688
-44
| -0.6% | -$3.04K | 0.04% | 333 |
|
|
2025
Q1 | $484K | Buy |
7,732
+4,220
| +120% | +$264K | 0.04% | 321 |
|
|
2024
Q4 | $302K | Buy |
3,512
+1,735
| +98% | +$149K | 0.03% | 379 |
|
|
2024
Q3 | $212K | Sell |
1,777
-1,932
| -52% | -$230K | 0.02% | 406 |
|
|
2024
Q2 | $529K | Buy |
3,709
+2,017
| +119% | +$288K | 0.05% | 277 |
|
|
2024
Q1 | $217K | Buy |
+1,692
| New | +$217K | 0.02% | 355 |
|
|
2017
Q4 | – | Sell |
-22,066
| Closed | -$531K | – | 103 |
|
|
2017
Q3 | $531K | Sell |
22,066
-21,468
| -49% | -$517K | 0.19% | 70 |
|
|
2017
Q2 | $934K | Sell |
43,534
-1,050
| -2% | -$22.5K | 0.36% | 45 |
|
|
2017
Q1 | $764K | Buy |
44,584
+23,942
| +116% | +$410K | 0.29% | 55 |
|
|
2016
Q4 | $370K | Buy |
+20,642
| New | +$370K | 0.15% | 65 |
|